Publication Name	World Journal of Hepatology
Manuscript ID	76723
Country	France

Received	2022-03-31 07:43
Peer-Review Started	2022-03-31 07:45
To Make the First Decision
Return for Revision	2022-05-12 08:31
Revised	2022-05-30 21:53
Second Decision	2022-06-27 03:08
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-06-27 16:54
Articles in Press	2022-06-27 16:54
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-06-22 01:44
Typeset the Manuscript	2022-07-01 01:16
Publish the Manuscript Online	2022-07-27 13:17

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Alfapump® implantable device in management of refractory ascites: An update
Manuscript Source	Unsolicited Manuscript
All Author List	Delphine Weil-Verhoeven, Vincent Di Martino, Guido Stirnimann, Jean Paul Cervoni, Eric Nguyen-Khac and Thierry Thévenot
Funding Agency and Grant Number
Corresponding Author	Delphine Weil-Verhoeven, MD, PhD, Doctor, Service d’Hépatologie Et Soins Intensifs Digestifs, CHRU Jean Minjoz, 3 Boulevard Fleming, Besançon 25030, France. dweil@chu-besancon.fr
Key Words	Alfapump; Refractory ascites; Automated low flow ascites pump; Cirrhosis; Liver
Core Tip	The alfapump® system (Sequana Medical, Ghent, Belgium) is a subcutaneous implantable device that allows the transfer of ascites from the peritoneal cavity to the bladder. In this review, we describe the practical aspects of the alfapump® device implantation, we discuss its effectiveness and safety as a treatment of refractory ascites in cirrhotic patients, based on the most recent published data.
Publish Date	2022-07-27 13:17
Citation	Weil-Verhoeven D, Di Martino V, Stirnimann G, Cervoni JP, Nguyen-Khac E, Thévenot T. Alfapump® implantable device in management of refractory ascites: An update. World J Hepatol 2022; 14(7): 1344-1356
URL	https://www.wjgnet.com/1948-5182/full/v14/i7/1344.htm
DOI	https://dx.doi.org/10.4254/wjh.v14.i7.1344

Full Article (PDF)	WJH-14-1344.pdf
Full Article (Word)	WJH-14-1344.docx
Manuscript File	76723_Auto_Edited-LM.docx
Answering Reviewers	76723-Answering reviewers.pdf
Audio Core Tip	76723-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	76723-Conflict-of-interest statement.pdf
Copyright License Agreement	76723-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	76723-Language certificate.pdf
Supplementary Material	76723-Supplementary material.pdf
Peer-review Report	76723-Peer-review(s).pdf
Scientific Misconduct Check	76723-Bing-Wang LL-2.jpg
Scientific Editor Work List	76723-Scientific editor work list.pdf